Wanji S, Chunda V, Fombad F, Njouendou A, Gandjui N, Ritter M
Front Trop Dis. 2024; 2.
PMID: 38654889
PMC: 7615857.
DOI: 10.3389/fitd.2021.778724.
Amambo G, Abong R, Fombad F, Njouendou A, Nietcho F, Beng A
Parasit Vectors. 2021; 14(1):19.
PMID: 33407819
PMC: 7788981.
DOI: 10.1186/s13071-020-04506-3.
Pion S, Nana-Djeunga H, Niamsi-Emalio Y, Chesnais C, Deleglise H, Mackenzie C
Lancet Infect Dis. 2019; 20(1):102-109.
PMID: 31676244
PMC: 8150319.
DOI: 10.1016/S1473-3099(19)30554-7.
Vinkeles Melchers N, Coffeng L, Boussinesq M, Pedrique B, Pion S, Tekle A
Clin Infect Dis. 2019; 70(11):2281-2289.
PMID: 31304961
PMC: 7245158.
DOI: 10.1093/cid/ciz647.
Pion S, Tchatchueng-Mbougua J, Chesnais C, Kamgno J, Gardon J, Chippaux J
Open Forum Infect Dis. 2019; 6(4):ofz019.
PMID: 30968052
PMC: 6449757.
DOI: 10.1093/ofid/ofz019.
Comparison of different drug regimens for the treatment of loiasis-A TropNet retrospective study.
Gobbi F, Bottieau E, Bouchaud O, Buonfrate D, Salvador F, Rojo-Marcos G
PLoS Negl Trop Dis. 2018; 12(11):e0006917.
PMID: 30383753
PMC: 6233929.
DOI: 10.1371/journal.pntd.0006917.
Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S, Ndongmo W, Fombad F, Kengne-Ouafo J, Njouendou A, Longang Tchounkeu Y
PLoS Negl Trop Dis. 2018; 12(9):e0006750.
PMID: 30226900
PMC: 6161907.
DOI: 10.1371/journal.pntd.0006750.
Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
Kamgno J, Nana-Djeunga H, Pion S, Chesnais C, Klion A, Mackenzie C
Int Health. 2018; 10(suppl_1):i49-i53.
PMID: 29471340
PMC: 6282645.
DOI: 10.1093/inthealth/ihx051.
Potential Role for Flubendazole in Limiting Filariasis Transmission: Observations of Microfilarial Sensitivity.
ONeill M, Njouendou J, Dzimianski M, Burkman E, Ndongmo P, Kengne-Ouafo J
Am J Trop Med Hyg. 2017; 98(1):21-26.
PMID: 29141764
PMC: 5928712.
DOI: 10.4269/ajtmh.17-0390.
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Kamgno J, Pion S, Chesnais C, Bakalar M, DAmbrosio M, Mackenzie C
N Engl J Med. 2017; 377(21):2044-2052.
PMID: 29116890
PMC: 5629452.
DOI: 10.1056/NEJMoa1705026.
Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment.
Wanji S, Eyong E, Tendongfor N, Ngwa C, Esuka E, Kengne-Ouafo A
PLoS Negl Trop Dis. 2017; 11(7):e0005576.
PMID: 28686693
PMC: 5533442.
DOI: 10.1371/journal.pntd.0005576.
Profiling the macrofilaricidal effects of flubendazole on adult female Brugia malayi using RNAseq.
ONeill M, Ballesteros C, Tritten L, Burkman E, Zaky W, Xia J
Int J Parasitol Drugs Drug Resist. 2016; 6(3):288-296.
PMID: 27733308
PMC: 5196492.
DOI: 10.1016/j.ijpddr.2016.09.005.
An In Vitro/In Vivo Model to Analyze the Effects of Flubendazole Exposure on Adult Female Brugia malayi.
ONeill M, Mansour A, DiCosty U, Geary J, Dzimianski M, McCall S
PLoS Negl Trop Dis. 2016; 10(5):e0004698.
PMID: 27145083
PMC: 4856366.
DOI: 10.1371/journal.pntd.0004698.
Genome Filtering for New DNA Biomarkers of Loa loa Infection Suitable for Loop-Mediated Isothermal Amplification.
Poole C, Ettwiller L, Tanner N, Evans Jr T, Wanji S, Carlow C
PLoS One. 2015; 10(9):e0139286.
PMID: 26414073
PMC: 4586141.
DOI: 10.1371/journal.pone.0139286.
Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.
Kouam M, Tchatchueng-Mbougua J, Demanou M, Boussinesq M, Pion S, Kamgno J
Parasit Vectors. 2013; 6(1):283.
PMID: 24289520
PMC: 3849770.
DOI: 10.1186/1756-3305-6-283.
Case report: Loiasis with peripheral nerve involvement and spleen lesions.
Gobbi F, Boussinesq M, Mascarello M, Angheben A, Gobbo M, Rossanese A
Am J Trop Med Hyg. 2011; 84(5):733-7.
PMID: 21540382
PMC: 3083740.
DOI: 10.4269/ajtmh.2011.10-0458.
A possible case of spontaneous Loa loa encephalopathy associated with a glomerulopathy.
Lukiana T, Mandina M, Situakibanza N, Mbula M, Lepira B, Odio W
Filaria J. 2006; 5:6.
PMID: 16686951
PMC: 1471781.
DOI: 10.1186/1475-2883-5-6.
Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future.
Twum-Danso N
Filaria J. 2004; 2 Suppl 1:S7.
PMID: 14975064
PMC: 2147656.
DOI: 10.1186/1475-2883-2-S1-S7.
Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.
Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux J
Filaria J. 2004; 2 Suppl 1:S4.
PMID: 14975061
PMC: 2147657.
DOI: 10.1186/1475-2883-2-S1-S4.
Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases.
Twum-Danso N
Filaria J. 2004; 2 Suppl 1:S3.
PMID: 14975060
PMC: 2147655.
DOI: 10.1186/1475-2883-2-S1-S3.
